Log In
BCIQ
Print this Print this
 

K-828-AB

  Manage Alerts
Collapse Summary General Information
Company Kowa Co. Ltd.
DescriptionOral GABA transaminase inhibitor
Molecular Target GABA transaminase
Mechanism of ActionGABA transaminase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationCognitive dysfunction
Indication DetailsTreat behavioral and psychological symptoms of dementia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today